Ingram Pinn illustration
©Ingram Pinn

Obama’s false choice: war-war or jaw-jaw

War – cold or hot – against Russia is not an answer but neither is pointless discussion

Exclusive online comment

The fund must recognise that fiscal stimulus is sometimes but not always a sensible policy response to weak demand
– Andrew Smithers
The country faces an unprecedented and unyielding set of international and domestic challenges
– Kurt Campbell
My question is whether television’s gain is going to be satire’s loss
– Jurek Martin

Strip banks of the power to create money

The giant hole at the heart of our market economies needs to be plugged

The millstone of $5tn state-backed loans

The problem with quick crisis-fighting ‘fixes’ is they sow the seeds of the next crisis

A chance to repeat Mandela’s miracle

The ANC’s era of reconciliation faces an uncertain future, writes Colin Coleman

College life ain’t what it used to be

The dream of escaping Loserville and meeting Miss Perfect has been shattered by nerdy needs

Tie-ups hit right note for music streaming

Spotify deal shows how telecoms can provide marketing muscle

FT Editorial

Fears deepen amid Thai battle for power

If Yingluck is ousted as premier her supporters may strike back

ECB QE: real prospect or fantasy game?

And will it work to weaken euro and stave off deflation?

Barclays’ chief suffers maul of the same

Roar of protest as third of voters fail to back pay report

Ingram Pinn illustration
©Ingram Pinn

Pharma needs research, not cuts

If the entire industry adopted Valeant’s approach, drug discovery would grind to a halt

YOUR VIEWS

Write a letter to the Editor of the Financial Times at letters.editor@ft.com